HECLA MINING CO (HL)

US4227041062 - Common Stock

5.3191  +0.04 (+0.74%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to HL. HL was compared to 155 industry peers in the Metals & Mining industry. HL may be in some trouble as it scores bad on both profitability and health. HL has a expensive valuation and it also scores bad on growth.



3

1. Profitability

1.1 Basic Checks

In the past year HL has reported negative net income.
HL had a positive operating cash flow in the past year.
HL had negative earnings in 4 of the past 5 years.
HL had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

HL has a Return On Assets (-2.82%) which is comparable to the rest of the industry.
HL has a Return On Equity of -4.31%. This is comparable to the rest of the industry: HL outperforms 45.81% of its industry peers.
With a Return On Invested Capital value of 0.87%, HL perfoms like the industry average, outperforming 47.74% of the companies in the same industry.
HL had an Average Return On Invested Capital over the past 3 years of 1.50%. This is significantly below the industry average of 9.26%.
Industry RankSector Rank
ROA -2.82%
ROE -4.31%
ROIC 0.87%
ROA(3y)-0.95%
ROA(5y)-1.37%
ROE(3y)-1.42%
ROE(5y)-2.1%
ROIC(3y)1.5%
ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 4.38%, HL is in line with its industry, outperforming 52.90% of the companies in the same industry.
In the last couple of years the Operating Margin of HL has declined.
HL has a Gross Margin of 15.69%. This is comparable to the rest of the industry: HL outperforms 51.61% of its industry peers.
In the last couple of years the Gross Margin of HL has grown nicely.
Industry RankSector Rank
OM 4.38%
PM (TTM) N/A
GM 15.69%
OM growth 3Y-31.04%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.34%
GM growth 5Y2.37%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HL is destroying value.
The number of shares outstanding for HL has been increased compared to 1 year ago.
Compared to 5 years ago, HL has more shares outstanding
HL has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 1.98 indicates that HL is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of HL (1.98) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.33 indicates that HL is not too dependend on debt financing.
The Debt to Equity ratio of HL (0.33) is worse than 65.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z 1.98
ROIC/WACC0.1
WACC8.59%

2.3 Liquidity

A Current Ratio of 1.65 indicates that HL should not have too much problems paying its short term obligations.
HL has a Current ratio of 1.65. This is in the lower half of the industry: HL underperforms 70.32% of its industry peers.
HL has a Quick Ratio of 1.06. This is a normal value and indicates that HL is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.06, HL is not doing good in the industry: 67.10% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.06

3

3. Growth

3.1 Past

The earnings per share for HL have decreased strongly by -123.81% in the last year.
HL shows a small growth in Revenue. In the last year, the Revenue has grown by 0.19%.
The Revenue has been growing slightly by 4.90% on average over the past years.
EPS 1Y (TTM)-123.81%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-300%
Revenue 1Y (TTM)0.19%
Revenue growth 3Y1.35%
Revenue growth 5Y4.9%
Revenue growth Q2Q-17.51%

3.2 Future

HL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 87.27% yearly.
Based on estimates for the next years, HL will show a small growth in Revenue. The Revenue will grow by 3.17% on average per year.
EPS Next Y11.73%
EPS Next 2Y276.22%
EPS Next 3Y165.61%
EPS Next 5Y87.27%
Revenue Next Year9.75%
Revenue Next 2Y3.07%
Revenue Next 3Y3.17%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

HL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

HL's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.76

4.3 Compensation for Growth

HL's earnings are expected to grow with 165.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y276.22%
EPS Next 3Y165.61%

3

5. Dividend

5.1 Amount

HL has a yearly dividend return of 0.27%, which is pretty low.
HL's Dividend Yield is comparable with the industry average which is at 2.87.
With a Dividend Yield of 0.27, HL pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 0.27%

5.2 History

On average, the dividend of HL grows each year by 18.37%, which is quite nice.
HL has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of HL decreased recently.
Dividend Growth(5Y)18.37%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

The earnings of HL are negative and hence is the payout ratio. HL will probably not be able to sustain this dividend level.
The dividend of HL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-18.54%
EPS Next 2Y276.22%
EPS Next 3Y165.61%

HECLA MINING CO

NYSE:HL (4/19/2024, 11:10:08 AM)

5.3191

+0.04 (+0.74%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.33B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.27%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.82%
ROE -4.31%
ROCE
ROIC
ROICexc
ROICexgc
OM 4.38%
PM (TTM) N/A
GM 15.69%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.65
Quick Ratio 1.06
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-123.81%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y11.73%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)0.19%
Revenue growth 3Y1.35%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y